Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taussig

Showing results (501-510 of 561) with videos related to

Pageof 57
Sort By:
Blood|April 22, 2015
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivoFarideh Miraki-Moud, Essam Ghazaly, Linda Ariza-McNaughton, et al.
MMWR. Morbidity and Mortality Weekly Report|September 12, 2024
Progress Toward Achieving National HIV/AIDS Strategy Goals for Quality of Life Among Persons Aged ≥50 Years with Diagnosed HIV - Medical Monitoring Project, United States, 2017-2023Linda Beer, Yunfeng Tie, Stacy M Crim, et al.
Journal of Pediatric Orthopedics|June 20, 2015
Prevalence of Hypertension in Pediatric Tibia Vara and Slipped Capital Femoral EpiphysisMatthew D Taussig, Kenneth P Powell, Heather A Cole, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 29, 2021
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic DiseasesLe-Duy Do, Christian P Moritz, Sergio Muñiz-Castrillo, et al.
Nucleic Acids Research|December 8, 2017
Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAsDaniel E Ryan, David Taussig, Israel Steinfeld, et al.
Mbio|November 13, 2014
QseC inhibitors as an antivirulence approach for Gram-negative pathogensMeredith M Curtis, Regan Russell, Cristiano G Moreira, et al.
Blood Advances|December 21, 2021
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AMLAmer M Zeidan, Isaac Boss, C L Beach, et al.
Biochemistry|April 18, 2022
Phosphonoacetate Modifications Enhance the Stability and Editing Yields of Guide RNAs for Cas9 EditorsDaniel E Ryan, Tamar Diamant-Levi, Israel Steinfeld, et al.
Mabs|August 5, 2020
The Antibody Society's antibody validation webinar seriesJan L A Voskuil, Anita Bandrowski, C Glenn Begley, et al.
Science (New York, N.Y.)|August 23, 2008
Targeting QseC signaling and virulence for antibiotic developmentDavid A Rasko, Cristiano G Moreira, De Run Li, et al.
Pageof 57

Showing results (501-510 of 561) with videos related to

Sort By:
Pageof 57
Blood|April 22, 2015
Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivoFarideh Miraki-Moud, Essam Ghazaly, Linda Ariza-McNaughton, et al.
MMWR. Morbidity and Mortality Weekly Report|September 12, 2024
Progress Toward Achieving National HIV/AIDS Strategy Goals for Quality of Life Among Persons Aged ≥50 Years with Diagnosed HIV - Medical Monitoring Project, United States, 2017-2023Linda Beer, Yunfeng Tie, Stacy M Crim, et al.
Journal of Pediatric Orthopedics|June 20, 2015
Prevalence of Hypertension in Pediatric Tibia Vara and Slipped Capital Femoral EpiphysisMatthew D Taussig, Kenneth P Powell, Heather A Cole, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 29, 2021
Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic DiseasesLe-Duy Do, Christian P Moritz, Sergio Muñiz-Castrillo, et al.
Nucleic Acids Research|December 8, 2017
Improving CRISPR-Cas specificity with chemical modifications in single-guide RNAsDaniel E Ryan, David Taussig, Israel Steinfeld, et al.
Mbio|November 13, 2014
QseC inhibitors as an antivirulence approach for Gram-negative pathogensMeredith M Curtis, Regan Russell, Cristiano G Moreira, et al.
Blood Advances|December 21, 2021
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AMLAmer M Zeidan, Isaac Boss, C L Beach, et al.
Biochemistry|April 18, 2022
Phosphonoacetate Modifications Enhance the Stability and Editing Yields of Guide RNAs for Cas9 EditorsDaniel E Ryan, Tamar Diamant-Levi, Israel Steinfeld, et al.
Mabs|August 5, 2020
The Antibody Society's antibody validation webinar seriesJan L A Voskuil, Anita Bandrowski, C Glenn Begley, et al.
Science (New York, N.Y.)|August 23, 2008
Targeting QseC signaling and virulence for antibiotic developmentDavid A Rasko, Cristiano G Moreira, De Run Li, et al.
Pageof 57